Mark Wildgust/X
May 25, 2025, 11:12
Mark Wildgust: Looking forward to ASCO25 starting next week
Mark Wildgust, The Janssen Pharmaceutical Companies of Johnson and Johnson, shared a post on X:
“Looking forward to ASCO25 starting next week and right after it EHA25.
Amazing data and opportunities to connect and come together as a community with our shared goals of Getting In Front of Cancer.”
Mark Wildgust expressed enthusiasm for the upcoming ASCO25 and EHA25 meetings, emphasizing data sharing and collaboration in the oncology community.
More posts featuring Mark Wildgust.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 8, 2025, 17:03
Jun 8, 2025, 16:53